The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Eczema
Clinical trial NCT05003453 · COMPLETED
Trial details
- NCT number
- NCT05003453
- Sponsor
- RDC Clinical Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-29
- Primary completion
- 2022-06-03
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.